Q1 2026 Holdings
Filed 2026-05-15 | 75 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $40.3K | 1,610 | 0.0% |
| ImageneBio Inc(IMA) | COM | 45175G207 | $159.4K | 31,884 | 0.0% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $491.8K | 14,689 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT) | COM | 097702203 | $556.4K | 137,721 | 0.0% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $586.6K | 141,700 | 0.0% |
| Septerna Inc(SEPN) | COM | 81734D104 | $1.1M | 47,506 | 0.0% |
| Wave Life Sciences Ltd(WVE) | SHS | Y95308105 | $1.4M | 189,253 | 0.1% |
| Jade Biosciences Inc(JBIO) | COM | 008064206 | $1.5M | 107,391 | 0.1% |
| Tenax Therapeutics Inc(TENX) | COM | 88032L605 | $1.7M | 104,400 | 0.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.7M | 78,551 | 0.1% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $1.9M | 33,930 | 0.1% |
| Savara Inc(SVRA) | COM | 805111101 | $2.0M | 364,763 | 0.1% |
| Nextcure Inc(NXTC) | COM | 65343E207 | $2.4M | 222,654 | 0.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.5M | 27,591 | 0.1% |
| Compass Therapeutics Inc(CMPX)Call | COM | 20454B104 | $2.6M | 500,000 | 0.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $2.9M | 50,600 | 0.1% |
| Harmony Biosciences Hldgs Inc(HRMY) | COM | 413197104 | $4.3M | 152,695 | 0.2% |
| Veradermics Inc(MANE) | COMMON STOCK | 922967104 | $4.6M | 73,315 | 0.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $5.0M | 78,320 | 0.2% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $6.0M | 91,791 | 0.2% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $6.5M | 344,166 | 0.2% |
| AxoGen Inc(AXGN) | COM | 05463X106 | $7.0M | 210,665 | 0.3% |
| Ultragenyx Pharmaceutical Inc(RARE)Call | COM | 90400D108 | $7.3M | 350,000 | 0.3% |
| Replimune Group Inc(REPL)Call | COM | 76029N106 | $7.8M | 1,015,400 | 0.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $7.8M | 204,015 | 0.3% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $8.3M | 395,081 | 0.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $8.6M | 679,578 | 0.3% |
| Exelixis Inc(EXEL)Put | COM | 30161Q104 | $10.8M | 251,500 | 0.4% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $10.9M | 2,056,161 | 0.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $12.2M | 386,498 | 0.5% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $13.2M | 477,995 | 0.5% |
| AnaptysBio Inc(ANAB) | COM | 032724106 | $13.8M | 248,253 | 0.5% |
| Stryker Corporation(SYK) | COM | 863667101 | $14.6M | 44,480 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $17.7M | 305,216 | 0.7% |
| Liquidia Corporation(LQDA)Put | COM | 53635D202 | $18.9M | 500,000 | 0.7% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $19.9M | 923,086 | 0.8% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $20.2M | 752,261 | 0.8% |
| Praxis Precision Medicines Inc(PRAX) | COM | 74006W207 | $20.5M | 63,680 | 0.8% |
| Pfizer Inc(PFE)Call | COM | 717081103 | $22.5M | 800,000 | 0.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $23.1M | 818,328 | 0.9% |
| Dexcom Inc(DXCM) | COM | 252131107 | $24.7M | 393,576 | 0.9% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $27.3M | 406,029 | 1.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $29.6M | 1,633,897 | 1.1% |
| BridgeBio Pharma Inc(BBIO) | COM | 10806X102 | $30.4M | 409,183 | 1.2% |
| Axsome Therapeutics Inc.(AXSM)Put | COM | 05464T104 | $33.8M | 200,000 | 1.3% |
| Celcuity Inc(CELC)Put | COM | 15102K100 | $34.2M | 300,000 | 1.3% |
| Immatics N.v(IMTX) | SHS | N44445109 | $35.7M | 3,630,454 | 1.4% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $36.0M | 212,747 | 1.4% |
| Nektar Therapeutics(NKTR) | COM | 640268306 | $36.7M | 509,546 | 1.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $37.2M | 1,701,904 | 1.4% |